A nationwide multicenter study investigates the long-term exposure to PM2.5 and its association with adverse pregnancy events in women with pulmonary hypertension. The findings contribute to understanding environmental impacts on pregnancy outcomes in this vulnerable population.

A case report details the late presentation of Lutembacher syndrome in an elderly female, highlighting severe pulmonary hypertension and tricuspid regurgitation complications. This case underscores the need for awareness of Lutembacher syndrome in older patients.

A recent EUSTAR cohort study evaluates the effectiveness of oral anticoagulants in treating precapillary pulmonary hypertension linked to systemic sclerosis. The findings contribute to understanding treatment options for this rare condition.

Roivant reports positive results from the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease (PH-ILD). The study highlights the drug's potential in addressing significant unmet medical needs in this progressive condition.

David Ross continues to advocate for rare diseases, particularly pulmonary hypertension associated with interstitial lung disease (PH-ILD), two decades after losing his loved one. His advocacy highlights the ongoing need for compassion and dedication in supporting patients facing these challenges.